Results 141 to 150 of about 12,266 (204)

The Comparative Effectiveness of PDE5 Inhibitors and β3 Agonists Versus α-Blockers in Medical Expulsive Therapy for Distal Ureteric Stones: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Cureus
Ramanah M, Banerjee I, Nunkoo S, Robinson J, Krissheeven M, Banerjee I.   +5 more
europepmc   +1 more source

The safety and efficacy of PDE5-inhibitors-vardenafil on treating diabetes mellitus erectile dysfunction: A protocol for systematic review and meta analysis. [PDF]

Medicine (Baltimore), 2019
He J, Li X, Dai HH, Wang JS, Li HS, Zhang XJ, Wang P, Zhang D, Zuo LY, Xie N, Li Y.   +10 more
europepmc   +1 more source

Future perspectives for PDE5 inhibitors bridging the gap between cardiovascular health and psychological status. [PDF]

Basic Clin Androl
Sansone A, Guida E, Dolci S, Frangione V, Asso A, Bellia G, Jannini EA.   +6 more
europepmc   +1 more source

Further reassurance regarding PDE5 inhibitors

International Journal of Clinical Practice, 2007
openaire   +1 more source

PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery. [PDF]

Br J Pharmacol, 2018
Andersson KE.
europepmc   +1 more source

Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents. [PDF]

Ecancermedicalscience, 2018
Pantziarka P, Sukhatme V, Crispino S, Bouche G, Meheus L, Sukhatme VP.   +5 more
europepmc   +1 more source

The Beneficial Effects of Alpha-Blockers, Antimuscarinics, Beta 3-Agonist, and PDE5-Inhibitors for Ureteral Stent-Related Discomfort: A Systematic Review and Meta-Analysis from KSER Update Series. [PDF]

Medicina (Kaunas)
Moon YJ, Chung DY, Kim DK, Jung HD, Jeon SH, Kang SH, Paick S, Lee JY, Korean Society of Endourology and Robotics (KSER) Research Committee.   +8 more
europepmc   +1 more source

Efficacy and safety of PDE5 inhibitors in the treatment of diabetes mellitus erectile dysfunction: Protocol for a systematic review. [PDF]

Medicine (Baltimore), 2018
Li X, Zhao Q, Wang J, Wang J, Dai H, Li H, Wang B.   +6 more
europepmc   +1 more source

Can Combination Therapy with Endothelin Receptor Antagonist and PDE5 Inhibitors Prevent Echocardiographic Findings Suspicious for Pulmonary Arterial Hypertension? Description of a Real-Life Case Series. [PDF]

Diagnostics (Basel)
Damiani A, Lepri G, Bonomi F, Fiorentini E, Peretti S, Blagojevic J, Bellando Randone S, Guiducci S.   +7 more
europepmc   +1 more source

PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]. [PDF]

Oncotarget, 2017
Booth L, Roberts JL, Poklepovic A, Dent P.   +3 more
europepmc   +1 more source